EQA Scheme
Contact
Molecular Oncology – PML::RARA qualitative (702)
Samples:
2 samples of 30 µL
Sample properties:
cDNA solution
Additional Information:
As required by the RiliBÄK, the method used must have a detection limit of at least 5%.
Requirement for EQAS/PT according to Rili-BÄK
Parameters:
PML::RARA gene fusion
Certificate Validity: 12 months
Not subject to Rili-BÄK
Parameters:
not applicable
Certificate Validity: not applicable
Shipping Information:
Shipping not cooled
Safety Information:
Process as patient sample material
Dates:
Registration deadline:
Sample shipment:
Closing Date:
| Apr. (2) | Nov. (6) |
|---|---|
| 08.01.2027 | 06.08.2027 |
| 09.03.2027 | 05.10.2027 |
| 09.04.2027 | 05.11.2027 |
EQAS/PT Experts:
Prof. Dr. Karl-Anton Kreuzer
Universitätsklinikum Köln
Innere Medizin I
Kerpener Straße 62
50937 Köln
+49 221 478 97626
karl-anton.kreuzer@uni-koeln.de
Dr. rer. nat. Eva Lorsy
Universitätsklinikum Köln
Kerpener Straße 62
50937 Köln
+49 221 478 98828
eva.lorsy@instand-ringversuch.de